US STOCK
ELV Stock Analysis
US stocks · market data · technical indicators
Elevance Health, Inc.
ELVUS stocksQuote delayed 15 min
10/26 下午10:50 updated
$439.80
-0.15-0.04%
Open
$441.30
High
$442.25
Low
$437.69
Volume
9.95萬
ELV price history
+10.99%Open
394.59
Latest
437.96
High
445.28
Low
381.67
Average
415.08
Advertisement
Financial snapshot
ELV - Elevance Health, Inc.
EPS
23.55USD
Forward EPS
30.22USD
P/E
18.60x
Forward P/E
14.49x
P/B
2.12x
ROE
11.48%
ROA
4.01%
Operating margin
4.22%
Profit margin
2.55%
Revenue growth
1.40%
Earnings growth
17.90%
Dividend yield
1.56%
Financial statements
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| Revenue | $51.43B | $50.47B | $50.18B | $49.75B | $50.71B |
| Net income | $1.36B | $1.46B | $1.76B | $547.00M | $1.19B |
| Basic EPS | 6.30 | 6.74 | 8.03 | 2.48 | 5.35 |
| Diluted EPS | 6.27 | 6.71 | 8.00 | 2.47 | 5.32 |
Estimates vs actuals
Next earnings
2027-01-28
EPS estimate
2.00
Revenue estimate
$48.86B
Last surprise
+48.89%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2027-01-28 | 2.00 | Not reported | — |
| 2026-10-21 | 4.69 | 6.99 | +48.89% |
| 2026-07-15 | 6.21 | 7.45 | +19.99% |
| 2026-04-22 | 10.81 | 12.58 | +16.36% |
| 2026-01-28 | 3.09 | 3.33 | +7.65% |
| 2025-10-21 | 4.94 | 6.03 | +22.01% |
| 2025-07-17 | 8.92 | 8.84 | -0.91% |
| 2025-04-22 | 11.48 | 11.97 | +4.30% |
| 2025-01-23 | 3.85 | 3.84 | -0.29% |
| 2024-10-17 | 9.65 | 8.37 | -13.28% |
| 2024-07-17 | 10.01 | 10.12 | +1.14% |
| 2024-04-18 | 10.53 | 10.64 | +1.08% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| BlackRock Inc. | 2024-06-30 | $11.2B | 0.25% |
| VANGUARD GROUP INC | 2025-12-31 | $8.1B | 0.12% |
| STATE STREET CORP | 2026-06-30 | $4B | 0.12% |
| CITADEL ADVISORS LLC | 2026-06-30 | $350.5M | 0.04% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $77.9M | 0.11% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $62.7M | 0.05% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$481.48
Target range
$406.00 – $523.00
Implied upside
9.95%
Strong buy
2
Buy
12
Hold
8
Sell
0
Strong sell
0
Dividends
Annual yield
1.56%
Frequency
Quarterly
Recent payouts
- 2026-09-10$1.7200
- 2026-06-10$1.7200
- 2026-03-10$1.7200
- 2025-12-05$1.7100
Advertisement